Press tips from ShareCast
Friday tips round-up: BAE Systems, Reed Elsevier, Morgan Crucible
BAE Systems shares are trading on a December 2010 earnings multiple of just 8.5 times, which is a discount to US peers.
For example, General Dynamics is trading on a current-year multiple of 10.6 times. If BAE shares were rated at the same level as this equivalent US business, the share price would be in the order of 435p, some 21% above the current share price. Buy says the Telegraph.
Reed Elsevier will feel the effects of the recession especially keenly in the first half of the year as companies in other sectors struggle. The company did well to hold its dividend at 20.4p this year. However, trading at 11.5 times earnings, it looks far from cheap. Hold says the Times.
Mark Robertshaw, chief executive of Morgan Crucible, is pushing a simple message to the City today: "We are a completely different business." With the final dividend maintained at 4.5p, giving 7p for the year, the closing price last night of 169œp yields an attractive 4.2 per cent. Engineering businesses are geared well for a global recovery and well-run companies more so. Continue to add says the Times.
The shares trade at a shade under 12 times 2010 earnings and could enjoy a re-rating once sales growth kicks in. That might not be as far away as the sceptics think. Buy says the Independent.
Cancer drug developer Antisoma is still loss-making. Its first-half pre-tax loss tripled to £21.3m as it made no revenue but it will record revenue of about £20m in the second half from the sale of fludarabine, a leukaemia drug, to Sanofi-Aventis. There is also the prospect that Novartis will snap Antisoma up if AS404 is successful. At 35œp, down 1p, take a look if you're feeling brave suggests the Times.
Ladbrokes took a kicking yesterday after what looked like a dispiriting set of results. Its revenues fell to £963.7m from £1.05bn a year ago, while profits before tax dipped from £265.6m to £191.3m. The shares are not cheap. on 13.1 times forecast 2010 earnings, much more expensive than, say, William Hill. But there is potential enough to continue holding says the Independent.
Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.
For example, General Dynamics is trading on a current-year multiple of 10.6 times. If BAE shares were rated at the same level as this equivalent US business, the share price would be in the order of 435p, some 21% above the current share price. Buy says the Telegraph.
Reed Elsevier will feel the effects of the recession especially keenly in the first half of the year as companies in other sectors struggle. The company did well to hold its dividend at 20.4p this year. However, trading at 11.5 times earnings, it looks far from cheap. Hold says the Times.
Mark Robertshaw, chief executive of Morgan Crucible, is pushing a simple message to the City today: "We are a completely different business." With the final dividend maintained at 4.5p, giving 7p for the year, the closing price last night of 169œp yields an attractive 4.2 per cent. Engineering businesses are geared well for a global recovery and well-run companies more so. Continue to add says the Times.
The shares trade at a shade under 12 times 2010 earnings and could enjoy a re-rating once sales growth kicks in. That might not be as far away as the sceptics think. Buy says the Independent.
Cancer drug developer Antisoma is still loss-making. Its first-half pre-tax loss tripled to £21.3m as it made no revenue but it will record revenue of about £20m in the second half from the sale of fludarabine, a leukaemia drug, to Sanofi-Aventis. There is also the prospect that Novartis will snap Antisoma up if AS404 is successful. At 35œp, down 1p, take a look if you're feeling brave suggests the Times.
Ladbrokes took a kicking yesterday after what looked like a dispiriting set of results. Its revenues fell to £963.7m from £1.05bn a year ago, while profits before tax dipped from £265.6m to £191.3m. The shares are not cheap. on 13.1 times forecast 2010 earnings, much more expensive than, say, William Hill. But there is potential enough to continue holding says the Independent.
Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.
Recent articles
-
Friday tips round up: Vodafone, Rio Tinto, Mitchells and Butlers
Fri 10 February 2012 06:59 -
Thursday tips round-up: International Power and BHP Billiton
Thu 09 February 2012 06:55 -
Wednesday tips round-up: Xstrata, Electrocomponents
Wed 08 February 2012 07:18 -
Tuesday tips round-up: Standard Life and Electrocomponents
Tue 07 February 2012 06:59 -
Sunday share tips: Compass, ZincOx, Johnson Matthey
Sun 05 February 2012 16:01
Press tips: Most read
-
Friday's tips round up: Misys, Gem and Standard Life
Fri 27 January 2012 07:20 -
Wednesday tips round up: National Grid, Babcock, Kcom
Wed 01 February 2012 06:51 -
Thursday tips round-up: United Utilities, Petra Diamonds
Thu 02 February 2012 06:54 -
Friday tips round-up: Imperial Tobacco, Unilever
Fri 03 February 2012 07:18 -
Sunday share tips: Compass, ZincOx, Johnson Matthey
Sun 05 February 2012 16:01
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Market latest
FTSE 100 | FTSE 250 | All Share
| FTSE 100 | 5,851.82 | ![]() |
-0.74% |
| FTSE 250 | 11,154.41 | ![]() |
-0.71% |
| FTSE All Share | 3,023.98 | ![]() |
-0.73% |
| Dow Jones | 12,890.46 | ![]() |
+0.05% |
| NASDAQ | 2,927.23 | ![]() |
+0.39% |
| Xetra DAX | 6,681.47 | ![]() |
-1.58% |
| Paris CAC 40 | 3,382.48 | ![]() |
-1.23% |
| Nikkei 225 | 8,947.17 | ![]() |
-0.61% |
| Hang Seng | 20,783.86 | ![]() |
-1.08% |
Hang Seng disclaimer l Prices delayed by at least 15 minutes
FTSE 100
| Barclays plc | 238.90 | ![]() |
+2.49% |
| ITV plc | 79.80 | ![]() |
+2.18% |
| Tate & Lyle plc | 685.00 | ![]() |
+1.86% |
| Next plc | 2763.00 | ![]() |
+1.62% |
| ARM Holdings plc | 570.00 | ![]() |
+1.51% |
| Man Group | 130.60 | ![]() |
-5.02% |
| Kazakhmys Plc | 1131.00 | ![]() |
-3.91% |
| ICAP Plc | 366.70 | ![]() |
-3.85% |
| Anglo American | 2754.50 | ![]() |
-3.69% |
| Bhp Billiton | 2043.50 | ![]() |
-3.38% |
| Lloyds Banking Group plc | 91,486,532 |
| Barclays plc | 63,997,801 |
| Royal Bank of Scotland | 55,093,359 |
| Vodafone Group Plc | 19,452,245 |
| Tesco Plc | 10,648,644 |
Articles on the economy and stock markets
Inflation falls at last
Wed 18 January 2012
With inflation finally falling, what does this mean for the economy and for investors? Ben Yearsley, Investment Manager discusses.
Where to invest in a recession
Tue 17 January 2012
It doesn't take an economist to see that the economic picture is fragile. But how bad are things likely to get, and what does it mean for investors? Ben Brettell, Economics Editor, examines the evidence.
Where to invest in 2012
Fri 13 January 2012
2012 starts where 2011 left off - with a huge degree of uncertainty for investors. Mark Dampier shares his thoughts on areas which could prosper this year.

